ZINC ACETATE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
59.0 -1.2 0 2 40.0 0 0.5
CAS
5970456
UNII
FM5526K07A
SYNONYMS
ZINC ID(s)
Availability
Present in 103 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
FYN Tyrosine-protein kinase Fyn Enzyme / Kinase
LCK Proto-oncogene tyrosine-protein kinase LCK Enzyme / Kinase

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT00211419 Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) Phase 1 Completed
NCT00002300 A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition Phase 2 Completed
NCT00000737 A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome Phase 1 Completed
NCT00501579 Study of Difluprednate in the Treatment of Uveitis Phase 3 Completed
NCT00227773 Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Phase 2 Withdrawn
NCT00002345 The Safety and Effectiveness of Megace in HIV-Infected Women Phase 4 Completed
NCT00517972 Omacor for Perimenopausal Depression Phase 2 Withdrawn
NCT00002167 Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. Phase 2 Completed
NCT00002067 A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia Phase 3 Completed
NCT00348244 Ketorolac vs. Steroid in the Prevention of CME Phase 4 Completed
NCT00003517 Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Phase 2 Withdrawn
NCT00486772 Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD Phase 4 Completed
NCT00211406 Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) Phase 1 Terminated
NCT00044837 Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women Phase 1 Terminated
NCT00433225 Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation Phase 4 Completed
NCT02285244 2017-05-01 Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation Phase 2 Withdrawn
NCT02393482 2015-04-01 Psychological Impact of Amenorrhea in Women With Endometriosis Phase 4 Not Yet Recruiting
NCT02370537 2015-04-01 A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI Phase 2 Not Yet Recruiting
NCT02379390 2015-04-01 Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz Phase 2 Not Yet Recruiting
NCT02353715 2015-04-01 Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing Phase 0 Not Yet Recruiting
NCT01939691 2015-03-01 Topical Treatment of Uveitic Macular Edema Phase 4 Not Yet Recruiting
NCT02335203 2015-02-01 The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy Phase 2 Recruiting
NCT02361905 2015-02-01 Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas Phase 4 Recruiting
NCT02357563 2015-02-01 Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation Phase 4 Recruiting
NCT02361892 2015-02-01 The Effect of Ulipristal Acetate (UPA) on Women Ovarian Reserve Phase 4 Recruiting
NCT02361879 2015-02-01 Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma Phase 4 Recruiting
NCT02314156 2015-02-01 Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy Phase 2 Not Yet Recruiting
NCT02228681 2015-02-01 Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer Phase 2 Not Yet Recruiting
NCT02278185 2015-02-01 Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer Phase 2 Not Yet Recruiting
NCT02160353 2015-01-01 Janssen Neo-adjuvant Abiraterone Prostate Study Phase 2 Not Yet Recruiting
NCT02346253 2015-01-01 High-Dose Brachytherapy in Treating Patients With Prostate Cancer Phase 1/Phase 2 Recruiting
NCT02323646 2014-12-01 A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids Phase 2 Recruiting
NCT02301897 2014-12-01 A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids Phase 2 Recruiting
NCT02336620 2014-12-01 Balanced Salt Solution VS. Normal Saline Solution in Septic Shock Phase 3 Active, Not Recruiting
NCT02272647 2014-12-01 Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women Phase 1 Not Yet Recruiting
NCT01973816 2014-11-01 MEdical Versus SUrgical Treatments of Rectal Endometriosis Phase 3 Recruiting
NCT02269670 2014-11-01 Everolimus and Hormone Therapy in Treating Patients With Advanced Hormone Receptor Positive Breast Cancer That Has Progressed or Recurred on Everolimus and Exemestane Therapy Phase 2 Recruiting
NCT02257736 2014-11-01 An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) Phase 3 Recruiting
NCT02268175 2014-10-01 Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate Phase 2 Recruiting
NCT02230046 2014-10-01 Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants Phase 1 Completed
NCT02203331 2014-10-01 Bay98-7196, Dose Finding / POC Study Phase 2 Recruiting
NCT02309385 2014-10-01 Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis Phase 1/Phase 2 Recruiting
NCT02212197 2014-09-01 Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer Phase 2 Recruiting
NCT02159690 2014-09-01 A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy Phase 2 Withdrawn
NCT02364531 2014-09-01 A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting Phase 4 Recruiting
NCT02217566 2014-09-01 Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy Phase 2 Recruiting
NCT02125357 2014-08-01 Sequencing Abiraterone and Enzalutamide in mCRPC Phase 2 Recruiting
NCT02218606 2014-08-01 Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer Phase 2 Recruiting
NCT02195635 2014-07-01 Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects Phase 1 Active, Not Recruiting
NCT02123758 2014-07-01 A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer Phase 1 Recruiting
NCT02090114 2014-06-01 RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study) Phase 2 Recruiting
NCT01763541 2014-06-01 Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading Phase 0 Withdrawn
NCT02077634 2014-05-01 Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE) Phase 2 Recruiting
NCT02058706 2014-05-01 LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer Phase 2 Recruiting
NCT02075606 2014-05-01 Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients Phase 4 Recruiting
NCT02064582 2014-05-01 Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer Phase 2 Recruiting
NCT02141061 2014-05-01 Comparison of Two Formulations of Proellex for Oral Administration Phase 1 Completed
NCT01994590 2014-05-01 Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Phase 2 Active, Not Recruiting
NCT01961934 2014-05-01 C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression Phase 2/Phase 3 Recruiting
NCT02023463 2014-04-01 Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer Phase 1 Recruiting
NCT02103660 2014-04-01 Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women Phase 4 Active, Not Recruiting
NCT02147197 2014-04-01 A Study of the Efficacy and Safety of a Single Ulipristal Treatment Course for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas Phase 3 Recruiting
NCT02097303 2014-03-01 Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis Phase 2 Recruiting
NCT01953679 2014-03-01 Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days Phase 2 Recruiting
NCT02115282 2014-03-01 Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic Phase 3 Recruiting
NCT02178449 2014-03-01 Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade Phase 4 Recruiting
NCT01943058 2014-03-01 Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer Phase 2 Withdrawn
NCT01976728 2014-02-01 LutrePulse Hypogonadotropic Hypogonadism Phase 3 Recruiting
NCT02147158 2014-01-01 A Study of the Safety and Efficacy of Intermittent Ulipristal Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas Phase 3 Recruiting
NCT02003209 2014-01-01 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Phase 3 Recruiting
NCT02023424 2014-01-01 An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome Phase 1 Recruiting
NCT02034552 2013-12-01 A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) Phase 2 Recruiting
NCT02025010 2013-12-01 Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates. Phase 2 Recruiting
NCT02140632 2013-12-01 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Phase 4 Enrolling By Invitation
NCT01843530 2013-11-01 Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema Phase 3 Recruiting
NCT01989780 2013-11-01 Bevacizumab Plus Paclitaxel Optimization Study With Interventional Maintenance Endocrine Therapy in Advanced or Metastatic ER-positive Human Epidermal Growth Factor Receptor 2(HER2)-Negative Breast Cancer Phase 2 Recruiting
NCT01913158 2013-10-01 Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids Phase 2 Active, Not Recruiting
NCT01940276 2013-10-01 Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer Phase 2 Recruiting
NCT01946165 2013-10-01 Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide Phase 2 Active, Not Recruiting
NCT01963611 2013-10-01 Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1) Phase 2 Active, Not Recruiting
NCT01968317 2013-10-01 Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma Phase 2 Recruiting
NCT01957436 2013-10-01 A Phase III of ADT +/- Local RT +/- Abiraterone Acetate in Metastatic Hormone-naïve Prostate Cancer. Phase 3 Recruiting
NCT01916252 2013-09-01 Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old Phase 3 Recruiting
NCT01950403 2013-09-01 Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers Phase 1 Active, Not Recruiting
NCT01003769 2013-09-01 Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia Phase 1/Phase 2 Recruiting
NCT01501396 2013-09-01 Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite Phase 2 Withdrawn
NCT01953965 2013-09-01 Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Right Ventricle (RV) Function and People With Pulmonary Hypertension Who Have Impaired RV Function. Using Imaging Studies PET Scan and Cardiac MRI. Phase 2 Recruiting
NCT01717053 2013-09-01 Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer Phase 2 Recruiting
NCT01917136 2013-08-01 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension Phase 2 Recruiting
NCT02153723 2013-08-01 Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone) Phase 2 Recruiting
NCT01848067 2013-08-01 Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer Phase 1/Phase 2 Recruiting
NCT02103764 2013-08-01 Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB Phase 3 Recruiting
NCT01913015 2013-07-01 Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer Phase 1 Terminated
NCT01842321 2013-07-01 Abiraterone Acetate in Molecular Apocrine Breast Cancer Phase 2 Recruiting
NCT01475643 2013-07-01 Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children. Phase 3 Recruiting
NCT02340013 2013-07-01 Endometrial Shedding Prior to Ovulation Induction Pilot Study Phase 4 Recruiting
NCT01723579 2013-07-01 Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017) Phase 3 Withdrawn
NCT01878708 2013-07-01 A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma Phase 0 Recruiting
NCT01867710 2013-07-01 Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy Phase 2 Recruiting
NCT01845792 2013-07-01 Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer Phase 2 Recruiting
NCT01853072 2013-06-01 Nepafenac Once Daily for Macular Edema - Study 1 Phase 3 Active, Not Recruiting
NCT01834209 2013-06-01 A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer Phase 3 Completed
NCT01872611 2013-06-01 Nepafenac Once Daily for Macular Edema - Study 2 Phase 3 Active, Not Recruiting
NCT01800422 2013-06-01 Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer Phase 2 Recruiting
NCT01692483 2013-06-01 Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer Phase 4 Withdrawn
NCT01814865 2013-05-01 Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer Phase 2 Withdrawn
NCT01873001 2013-05-01 A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants Phase 1 Completed
NCT01640964 2013-04-01 An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension Phase 2 Recruiting
NCT01674140 2013-04-01 S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Phase 3 Recruiting
NCT01853696 2013-03-01 Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty Phase 4 Active, Not Recruiting
NCT01503515 2013-03-01 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Phase 3 Recruiting
NCT01637402 2013-03-01 A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer Phase 2 Active, Not Recruiting
NCT01771328 2013-02-01 Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Phase 2 Recruiting
NCT01715285 2013-02-01 A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) Phase 3 Active, Not Recruiting
NCT01786265 2013-02-01 Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone Phase 2 Recruiting
NCT01792687 2013-02-01 Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate Phase 1 Active, Not Recruiting
NCT01868269 2013-02-01 Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Phase 3 Recruiting
NCT01776008 2013-01-01 Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer Phase 2 Recruiting
NCT01670656 2013-01-01 A Study to Evaluate the Effect of Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057) Phase 2 Completed
NCT01817530 2013-01-01 Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) Phase 2 Active, Not Recruiting
NCT01717898 2013-01-01 A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer Phase 1/Phase 2 Terminated
NCT01777061 2013-01-01 Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan Phase 3 Available
NCT01709318 2012-12-01 A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012) Phase 2 Completed
NCT01767090 2012-12-01 A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain Phase 2 Active, Not Recruiting
NCT01735396 2012-12-01 Abiraterone Acetate Trial in African American Prostate Cancer Patients Phase 2 Recruiting
NCT01751451 2012-12-01 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy Phase 2 Recruiting
NCT01681433 2012-12-01 OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone Phase 2 Recruiting
NCT01503229 2012-12-01 Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Phase 2 Recruiting
NCT01822288 2012-12-01 The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder Phase 4 Recruiting
NCT01747668 2012-11-01 Lactation Fortification Study Phase 3 Completed
NCT01708044 2012-11-01 Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM Phase 1 Completed
NCT01778283 2012-10-01 Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration Phase 4 Completed
NCT01712867 2012-10-01 The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels Phase 4 Active, Not Recruiting
NCT01696877 2012-09-01 A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer Phase 1/Phase 2 Active, Not Recruiting
NCT01638026 2012-09-01 Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG Phase 4 Active, Not Recruiting
NCT01631903 2012-09-01 Extension of Study ZPV-200 Phase 2 Completed
NCT01685125 2012-09-01 Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Phase 2 Recruiting
NCT01695135 2012-08-01 A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy Phase 3 Active, Not Recruiting
NCT01678573 2012-07-01 A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants Phase 1 Completed
NCT01469338 2012-07-01 Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel Phase 2 Terminated
NCT01642472 2012-07-01 PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata Phase 3 Active, Not Recruiting
NCT01608698 2012-06-01 Comparison of Body Weight Change During Contraception With Belara and Yasmin Phase 4 Enrolling By Invitation
NCT01595373 2012-06-01 Local Metabolic Effects of Ghrelin in Skeletal Muscle and Adipose Tissue Phase 0 Completed
NCT01650194 2012-06-01 A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients Phase 2 Active, Not Recruiting
NCT01640093 2012-05-01 A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet Phase 1 Completed
NCT01546987 2012-05-01 Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Phase 3 Active, Not Recruiting
NCT01530269 2012-04-01 C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma Phase 2 Recruiting
NCT01553123 2012-04-01 Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma Phase 3 Withdrawn
NCT00888082 2012-04-01 Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy Phase 3 Withdrawn
NCT01576770 2012-04-01 In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction? Phase 4 Recruiting
NCT01517802 2012-03-01 A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate Phase 3 Active, Not Recruiting
NCT01569113 2012-03-01 Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo. Phase 4 Completed
NCT02107391 2012-03-01 Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer Phase 2 Active, Not Recruiting
NCT01791413 2012-03-01 Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas Phase 1/Phase 2 Completed
NCT01288378 2012-03-01 Empirical Versus Preemptive Antifungal Therapy Phase 3 Recruiting
NCT01404117 2012-03-01 A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability Phase 2 Withdrawn
NCT01421368 2012-03-01 Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use Phase 1 Active, Not Recruiting
NCT01591122 2012-03-01 Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer Phase 3 Active, Not Recruiting
NCT01452685 2012-03-01 A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis Phase 2 Completed
NCT01511536 2012-03-01 Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer Phase 1 Completed
NCT01652495 2012-03-01 Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection Phase 4 Completed
NCT01576172 2012-03-01 Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Phase 2 Recruiting
NCT01578785 2012-03-01 An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) Phase 3 Terminated
NCT01569451 2012-02-01 Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy for MS Phase 2 Active, Not Recruiting
NCT01776203 2012-01-01 Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist Phase 4 Terminated
NCT01655147 2012-01-01 A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants Phase 1 Completed
NCT01669499 2012-01-01 Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009 Phase 3 Recruiting
NCT01534182 2012-01-01 Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC) Phase 4 Completed
NCT01543776 2012-01-01 Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer Phase 2 Recruiting
NCT01487863 2011-12-01 Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Phase 2 Active, Not Recruiting
NCT01495910 2011-12-01 A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency Phase 1 Completed
NCT01505088 2011-12-01 Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis Phase 3 Completed
NCT01482897 2011-12-01 Efficacy of corticoïd Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica Phase 3 Terminated
NCT01712295 2011-11-01 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts Phase 4 Recruiting
NCT01463202 2011-11-01 Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression Phase 4 Recruiting
NCT01511120 2011-11-01 The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols Phase 2 Recruiting
NCT01489254 2011-10-01 Efficacy and Safety of GTR in Comparison to Copaxone® Phase 3 Completed
NCT01448213 2011-10-01 Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK) Phase 2 Completed
NCT01396213 2011-10-01 A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease Phase 2 Completed
NCT01458301 2011-10-01 Efficacy and Safety of TAK-385 in the Treatment of Endometriosis Phase 2 Completed
NCT01368263 2011-09-01 Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer Phase 2 Terminated
NCT01461824 2011-09-01 Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects Phase 3 Active, Not Recruiting
NCT01431391 2011-09-01 Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer Phase 2 Completed
NCT01427907 2011-09-01 Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients Phase 4 Active, Not Recruiting
NCT01415960 2011-09-01 Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer Phase 3 Active, Not Recruiting
NCT01309672 2011-09-01 S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Phase 2 Active, Not Recruiting
NCT01441635 2011-09-01 Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids Phase 2 Completed
NCT01393730 2011-09-01 Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer Phase 2 Active, Not Recruiting
NCT01581359 2011-09-01 The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis Phase 4 Recruiting
NCT01413620 2011-08-01 Vitamin E Supplementation in Burn Patients Phase 1 Recruiting
NCT01381874 2011-08-01 A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy Phase 2 Active, Not Recruiting
NCT01431690 2011-08-01 Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals Phase 1 Completed
NCT01421173 2011-08-01 Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies Phase 1 Active, Not Recruiting
NCT01685983 2011-08-01 A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer Phase 2 Active, Not Recruiting
NCT01634321 2011-07-01 The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty Phase 4 Completed
NCT01442246 2011-06-01 Benefit Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients. Phase 3 Active, Not Recruiting
NCT01362764 2011-05-01 A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers Phase 1 Completed
NCT01296152 2011-05-01 Pharmacokinetic Interactions Between DMPA and LPV/Rit Among HIV-Infected Women Phase 2 Completed
NCT01314118 2011-05-01 IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen Phase 2 Active, Not Recruiting
NCT01257802 2011-05-01 GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases Phase 3 Recruiting
NCT01317004 2011-05-01 Patients With RRMS:Candidates for MS Therapy Change Phase 4 Completed
NCT01510106 2011-04-01 Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis Phase 3 Completed
NCT01304485 2011-04-01 PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma Phase 2 Recruiting
NCT01629173 2011-04-01 The Analysis and Applications of Dynamic Impression Insole Phase 0 Completed
NCT01307579 2011-04-01 Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy Phase 3 Recruiting
NCT01254864 2011-03-01 Maximum Androgen Depletion Phase 2 Active, Not Recruiting
NCT01200602 2011-03-01 Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy Phase 2 Terminated
NCT00939549 2011-03-01 High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis Phase 2 Suspended
NCT01291433 2011-03-01 Trial of Combined Pentoxifylline-tocopherol-clodronate vs Placebo in Radiation-induced Brachial Plexopathy Phase 3 Recruiting
NCT01009931 2011-03-01 Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies Phase 2 Active, Not Recruiting
NCT01391052 2011-01-01 Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding Phase 4 Recruiting
NCT01277497 2011-01-01 Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 Phase 4 Recruiting
NCT01191177 2011-01-01 Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease Phase 1/Phase 2 Recruiting
NCT01120236 2010-12-01 Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Phase 2 Active, Not Recruiting
NCT00961532 2010-12-01 Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept Phase 2 Completed
NCT01250886 2010-12-01 Acid-base Balance in Patients Undergoing Colonoscopy Phase 1 Enrolling By Invitation
NCT01045798 2010-12-01 Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) Phase 2 Terminated
NCT01162460 2010-12-01 Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures Phase 3 Active, Not Recruiting
NCT01129960 2010-11-01 Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain Phase 3 Terminated
NCT01216982 2010-11-01 Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders Phase 2 Active, Not Recruiting
NCT01247961 2010-11-01 Early Treatment With Dexamethasone in Mild Acute Pancreatitis Phase 2 Recruiting
NCT01217697 2010-11-01 Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Phase 3 Active, Not Recruiting
NCT01229943 2010-10-01 Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Phase 2 Active, Not Recruiting
NCT01191255 2010-10-01 A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis Phase 3 Completed
NCT01201798 2010-10-01 Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Phase 3 Completed
NCT01149356 2010-10-01 RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer Phase 1/Phase 2 Terminated
NCT01204476 2010-10-01 Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Phase 1 Active, Not Recruiting
NCT01194271 2010-09-01 Neoadjuvant Ipilimumab in Prostate Cancer Phase 2 Active, Not Recruiting
NCT01199146 2010-09-01 Abiraterone Post Ketoconazole for Prostate Cancer Phase 2 Active, Not Recruiting
NCT01124097 2010-09-01 Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia Phase 3 Terminated
NCT01124045 2010-08-01 Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery Phase 3 Completed
NCT01527513 2010-08-01 Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures Phase 2 Completed
NCT01180764 2010-08-01 Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia Phase 4 Withdrawn
NCT01160848 2010-08-01 Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients Phase 2 Completed
NCT01278290 2010-07-01 Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls Phase 4 Active, Not Recruiting
NCT01161563 2010-07-01 Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration Phase 4 Completed
NCT01163084 2010-07-01 Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer Phase 1/Phase 2 Active, Not Recruiting
NCT01167426 2010-07-01 Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Phase 3 Completed
NCT01144897 2010-06-01 PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy Phase 2 Active, Not Recruiting
NCT01091662 2010-06-01 Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Phase 3 Completed
NCT01156311 2010-05-01 BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis Phase 2 Completed
NCT01067521 2010-05-01 A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo Phase 3 Active, Not Recruiting
NCT01140217 2010-05-01 Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception Phase 3 Completed
NCT01422720 2010-04-01 Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients Phase 4 Completed
NCT01359475 2010-04-01 A Clinical Trial of an Acetal Resin Crown for Restoration of Primary Molars Phase 3 Completed
NCT01023061 2010-03-01 Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locally Advanced Prostate Cancer Phase 2 Active, Not Recruiting
NCT01058005 2010-03-01 Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis Phase 3 Terminated
NCT01086982 2010-03-01 Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg, Imported And Distributed By The Laboratory Chemical Pharmaceutical Bergamo Ltda., Compared To Product Sandostatin LAR ® (Octreotide Acetate LAR) 30 MG Manufactured By Novartis Biosciences S / A. Phase 1 Suspended
NCT01071083 2010-03-01 Treatment Interruption of Natalizumab Phase 2 Completed
NCT01011621 2010-02-01 Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis Phase 3 Not Yet Recruiting
NCT01065220 2010-02-01 Sex Steroids and the Serotonin Transporter Phase 4 Completed
NCT01017939 2010-01-01 A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1 Completed
NCT01047683 2009-12-01 Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL Phase 3 Completed
NCT00962156 2009-12-01 Scandinavian Starch for Severe Sepsis/Septic Shock Trial Phase 3 Completed
NCT01088529 2009-12-01 Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer Phase 2 Completed
NCT00997893 2009-12-01 Research Investigation of Soy and Estrogen Phase 2 Recruiting
NCT01047501 2009-12-01 Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) Phase 3 Completed
NCT01103518 2009-12-01 Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation Phase 4 Active, Not Recruiting
NCT00935168 2009-12-01 Crystalloid Versus Hydroxyethyl Starch Trials Phase 3 Completed
NCT01350973 2009-11-01 Efficacy of TAK-085 in Participants With Hypertriglyceridemia Phase 3 Completed
NCT00843570 2009-11-01 Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment Phase 4 Completed
NCT01350999 2009-11-01 Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia Phase 3 Completed
NCT00931879 2009-10-01 Lovaza® and Microvascular Function in Type 2 Diabetes Phase 4 Completed
NCT01076803 2009-10-01 Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients Phase 2 Completed
NCT00937768 2009-10-01 Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy Phase 2 Terminated
NCT00949962 2009-10-01 Post-operative or Early Salvage XRT and ADT for High Risk PCa Phase 3 Terminated
NCT01798628 2009-09-01 A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients Phase 1 Completed
NCT00936390 2009-09-01 Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Phase 3 Recruiting
NCT00910598 2009-09-01 Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) Phase 4 Recruiting
NCT01715259 2009-08-01 A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function Phase 1 Completed
NCT00910091 2009-08-01 The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer Phase 2 Completed
NCT00910247 2009-08-01 Eslicarbazepine Acetate Monotherapy Long Term Study Phase 3 Active, Not Recruiting
NCT02001571 2009-08-01 A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function Phase 1 Completed
NCT00891072 2009-07-01 Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Phase 1 Completed
NCT01550146 2009-07-01 Single Dose of Dexamethasone in Femur Fractures Phase 4 Recruiting
NCT00947752 2009-07-01 Safety of New Formulation of Glatiramer Acetate Phase 3 Completed
NCT00934219 2009-07-01 Triglyceride Lowering Study Phase 4 Recruiting
NCT00915902 2009-07-01 Fish Oil Study for High Triglyceride Levels in Children Phase 2/Phase 3 Completed
NCT00987558 2009-06-01 Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects Phase 1 Completed
NCT01624727 2009-06-01 Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids Phase 3 Active, Not Recruiting
NCT00927901 2009-06-01 Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma Phase 2 Completed
NCT00946920 2009-06-01 A Trial of Degarelix in Patients With Prostate Cancer Phase 3 Completed
NCT00844012 2009-05-01 Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain Phase 4 Not Yet Recruiting
NCT00910754 2009-05-01 A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1 Completed
NCT00866775 2009-04-01 Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Phase 3 Completed
NCT01991574 2009-04-01 Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion. Phase 0 Completed
NCT00887198 2009-04-01 Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer Phase 3 Active, Not Recruiting
NCT00889473 2009-04-01 Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease Phase 2 Completed
NCT00865540 2009-03-01 Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies Phase 4 Active, Not Recruiting
NCT00860158 2009-03-01 Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer Phase 2 Terminated
NCT01244334 2009-03-01 Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Phase 4 Completed
NCT00805870 2009-03-01 The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers Phase 2 Completed
NCT00848016 2009-02-01 Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery Phase 2 Completed
NCT00856635 2009-02-01 A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon) Phase 3 Completed
NCT00828178 2009-02-01 Efficacy of Fish Oil in Lupus Patients Phase 4 Completed
NCT01148420 2009-01-01 DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding Phase 4 Completed
NCT00805935 2009-01-01 Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS) Phase 4 Completed
NCT01218737 2009-01-01 Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation Phase 3 Completed
NCT00808132 2009-01-01 Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis Phase 3 Completed
NCT00833495 2009-01-01 Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation Phase 2 Completed
NCT00943956 2009-01-01 Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer Phase 1 Recruiting
NCT01113671 2009-01-01 Type 2 Diabetes Haptoglobin Phenotype and Vitamin E Phase 2/Phase 3 Completed
NCT00788541 2008-12-01 A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension Phase 2 Terminated
NCT00988429 2008-12-01 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Phase 3 Active, Not Recruiting
NCT00667446 2008-12-01 Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty Phase 3 Completed
NCT01123538 2008-12-01 Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile Phase 4 Active, Not Recruiting
NCT00773955 2008-11-01 R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer Phase 2 Completed
NCT00791089 2008-11-01 Effects of Fish Oil on Post Ablation Arrhythmias Phase 4 Recruiting
NCT00782717 2008-11-01 A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients Phase 2 Completed
NCT01185704 2008-11-01 Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) Phase 3 Completed
NCT00900237 2008-11-01 Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine Phase 1 Completed
NCT00755885 2008-10-01 Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer Phase 1/Phase 2 Recruiting
NCT00924807 2008-09-01 Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer Phase 1/Phase 2 Terminated
NCT00427349 2008-09-01 AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Phase 2 Active, Not Recruiting
NCT00898560 2008-09-01 Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive Phase 1 Completed
NCT00731172 2008-09-01 A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease Phase 2 Recruiting
NCT00729586 2008-09-01 Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer Phase 2 Active, Not Recruiting
NCT00924313 2008-09-01 Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer Phase 1/Phase 2 Completed
NCT00742820 2008-08-01 Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers Phase 1 Completed
NCT00717860 2008-08-01 A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) Phase 3 Completed
NCT00739830 2008-08-01 Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6) Phase 2 Completed
NCT00758199 2008-07-01 Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery Phase 4 Completed
NCT00771017 2008-07-01 Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer Phase 2 Withdrawn
NCT01654653 2008-07-01 Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients Phase 4 Completed
NCT00755924 2008-06-01 Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein Phase 1 Completed
NCT00635817 2008-06-01 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty Phase 3 Completed
NCT00823004 2008-06-01 Antagonist/Letrozole in Poor Responders Phase 1/Phase 2 Completed
NCT00691717 2008-06-01 Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension Phase 2/Phase 3 Completed
NCT00706784 2008-06-01 Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study Phase 1/Phase 2 Terminated
NCT00696410 2008-06-01 The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy Phase 1 Completed
NCT00694746 2008-06-01 Study of Fish Oil to Reduce ALT Levels in Adolescents Phase 1 Recruiting
NCT00705770 2008-05-01 A Multi-Dose Study With a Treatment for Open-Angle Glaucoma Phase 2/Phase 3 Withdrawn
NCT01107093 2008-05-01 Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) Surge Phase 2 Completed
NCT00687739 2008-05-01 Prevention of Obesity in Women Via Estradiol Regulation Phase 3 Recruiting
NCT00689078 2008-05-01 Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model Phase 4 Completed
NCT00638690 2008-05-01 Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy Phase 3 Completed
NCT00630799 2008-05-01 Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients Phase 3 Terminated
NCT00673387 2008-04-01 Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects Phase 2 Completed
NCT00528866 2008-04-01 Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy Phase 2 Active, Not Recruiting
NCT00651261 2008-04-01 Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Phase 3 Active, Not Recruiting
NCT00211432 2008-04-01 Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg) Phase 2 Completed
NCT00651326 2008-03-01 Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer Phase 3 Terminated
NCT00620451 2008-02-01 Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease Phase 2 Completed
NCT00626431 2008-02-01 A Study of Leuprolide to Treat Prostate Cancer Phase 3 Completed
NCT01135615 2008-01-01 Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) Phase 4 Completed
NCT00540722 2008-01-01 Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Phase 2 Completed
NCT00635648 2008-01-01 A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) Phase 3 Completed
NCT00601276 2007-12-01 Comparison of Two Pharmacological Treatments of Pedophilia Phase 3 Terminated
NCT00988156 2007-12-01 Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children Phase 3 Active, Not Recruiting
NCT00569127 2007-12-01 Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Phase 3 Active, Not Recruiting
NCT00589472 2007-11-01 Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer Phase 2 Active, Not Recruiting
NCT00981227 2007-11-01 Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia Phase 2 Completed
NCT00980746 2007-11-01 Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy Phase 2 Completed
NCT00605267 2007-10-01 Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment Phase 3 Completed
NCT00286234 2007-10-01 Niacin, N-3 Fatty Acids and Insulin Resistance Phase 4 Completed
NCT00541047 2007-10-01 Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS) Phase 3 Recruiting
NCT00811395 2007-10-01 Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis Phase 2 Completed
NCT00971295 2007-10-01 Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers Phase 1 Completed
NCT00532558 2007-10-01 Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia Phase 3 Terminated
NCT01596010 2007-10-01 Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women Phase 1 Completed
NCT00544440 2007-10-01 An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma Phase 2 Completed
NCT00512668 2007-09-01 Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer Phase 1 Terminated
NCT00544596 2007-09-01 R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer Phase 1 Completed
NCT00474851 2007-08-01 The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial Phase 2 Completed
NCT00865228 2007-07-01 Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia Phase 2 Terminated
NCT00600535 2007-07-01 A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer Phase 1 Completed
NCT01144143 2007-07-01 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Phase 4 Completed
NCT00577122 2007-07-01 Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer Phase 2 Completed
NCT00503581 2007-07-01 Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia Phase 2 Active, Not Recruiting
NCT00532311 2007-07-01 Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia Phase 3 Terminated
NCT01056042 2007-06-01 Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain Phase 4 Completed
NCT00451451 2007-06-01 Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis Phase 3 Completed
NCT00485303 2007-06-01 An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy Phase 2 Completed
NCT00503516 2007-06-01 Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients Phase 2/Phase 3 Terminated
NCT00483327 2007-06-01 Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate Phase 2 Completed
NCT00688961 2007-06-01 Effects of Omacor and Aspirin on Platelet Function Phase 0 Completed
NCT00489840 2007-05-01 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Phase 1/Phase 2 Completed
NCT00452556 2007-05-01 The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study Phase 2 Active, Not Recruiting
NCT00467649 2007-05-01 A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes Phase 4 Completed
NCT00477490 2007-05-01 Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia Phase 3 Completed
NCT00711607 2007-05-01 A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822) Phase 1 Completed
NCT00616551 2007-04-01 Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients Phase 3 Completed
NCT00447499 2007-04-01 Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel Phase 3 Completed
NCT00598312 2007-04-01 Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer Phase 3 Completed
NCT00475865 2007-04-01 Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis Phase 2 Completed
NCT00460811 2007-04-01 Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Phase 2 Completed
NCT00439751 2007-04-01 Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy Phase 3 Active, Not Recruiting
NCT01664728 2007-04-01 An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 Phase 1 Completed
NCT00451152 2007-03-01 Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma Phase 2 Completed
NCT00718289 2007-03-01 Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes Phase 4 Completed
NCT00442767 2007-02-01 Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus Phase 4 Completed
NCT00435045 2007-02-01 Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia Phase 3 Completed
NCT00498901 2007-02-01 Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer Phase 2 Terminated
NCT00913055 2007-02-01 Open Label Study of Octreotide Implant in Patients With Acromegaly Phase 2 Completed
NCT01157182 2007-02-01 Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions Phase 1 Completed
NCT00390403 2007-02-01 Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Phase 1 Completed
NCT00633347 2007-01-01 Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation Phase 4 Completed
NCT00420342 2007-01-01 Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension Phase 2 Completed
NCT00380406 2007-01-01 PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial Phase 3 Completed
NCT00051129 2007-01-01 Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) Phase 3 Completed
NCT00453960 2007-01-01 Genistein and Endometrial Hyperplasia Phase 2 Completed
NCT01181726 2007-01-01 Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions Phase 1 Completed
NCT00402337 2006-11-01 Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation Phase 2 Completed
NCT00487591 2006-11-01 An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia Phase 4 Completed
NCT00474383 2006-11-01 An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy Phase 2 Completed
NCT02283801 2006-11-01 Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine. Phase 1 Completed
NCT00402077 2006-11-01 A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects Phase 2 Completed
NCT00402363 2006-11-01 Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation Phase 3 Completed
NCT00423475 2006-10-01 Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer Phase 3 Completed
NCT00493064 2006-10-01 To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions Phase 2/Phase 3 Active, Not Recruiting
NCT00392925 2006-10-01 A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects Phase 2 Completed
NCT00507949 2006-10-01 Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight Phase 2 Completed
NCT00398489 2006-10-01 Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery Phase 2 Active, Not Recruiting
NCT00332657 2006-09-01 Anecortave Acetate Risk Reduction Trial (AART) Phase 3 Terminated
NCT00373100 2006-09-01 The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children Phase 3 Completed
NCT00398528 2006-09-01 An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis Phase 4 Terminated
NCT01007851 2006-09-01 Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles Phase 3 Terminated
NCT00570479 2006-09-01 Prophylactic Anecortave Acetate in Patients With a Retisert Implant Phase 1 Completed
NCT00337779 2006-08-01 Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA). Phase 3 Completed
NCT00466076 2006-08-01 Copaxone in Age Related Macular Degeneration Phase 2/Phase 3 Recruiting
NCT00370019 2006-08-01 Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure Phase 2 Withdrawn
NCT00360490 2006-07-01 Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS) Phase 3 Completed
NCT00357877 2006-07-01 Prevention of Adult Caries Study (PACS) Phase 3 Active, Not Recruiting
NCT00326625 2006-07-01 Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) Phase 2 Completed
NCT00544830 2006-07-01 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer Phase 2 Active, Not Recruiting
NCT00677664 2006-07-01 Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation Phase 4 Active, Not Recruiting
NCT00473746 2006-06-01 Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer Phase 1/Phase 2 Completed
NCT00637806 2006-06-01 Treatment of Cancer-Associated Anorexia Using Megestrol Acetate Concentrated Suspension Phase 3 Terminated
NCT00454571 2006-06-01 Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer Phase 2 Active, Not Recruiting
NCT00637728 2006-06-01 Treatment of Cancer-Anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients Phase 3 Terminated
NCT00638079 2006-06-01 Evaluating the Effect of Food on Absorption of Megace ES Phase 1 Completed
NCT00637403 2006-05-01 Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension Phase 1 Terminated
NCT00330395 2006-05-01 Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) Phase 2 Completed
NCT00313183 2006-04-01 A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus Phase 2 Completed
NCT00322348 2006-04-01 Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women Phase 2 Completed
NCT00348998 2006-04-01 Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer Phase 2 Active, Not Recruiting
NCT00329797 2006-03-01 Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy Phase 3 Completed
NCT00286481 2006-03-01 Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia Phase 3 Completed
NCT00320203 2006-03-01 Anecortave Acetate in Patients With Open-angle Glaucoma Phase 2 Completed
NCT00378690 2006-03-01 A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD Phase 3 Completed
NCT00891293 2006-03-01 A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ Phase 4 Completed
NCT00376064 2006-03-01 Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly Phase 4 Completed
NCT00845845 2006-03-01 Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH) Phase 2 Terminated
NCT00306748 2006-03-01 Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation Phase 2 Completed
NCT00548080 2006-03-01 Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) Phase 3 Completed
NCT01824602 2006-02-01 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder Phase 2 Terminated
NCT00296153 2006-02-01 Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment Phase 4 Completed
NCT00108732 2006-02-01 A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer Phase 2 Active, Not Recruiting
NCT00275262 2006-02-01 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation Phase 2 Terminated
NCT01153581 2006-02-01 Sex Hormones and Orthostatic Tolerance Phase 2 Completed
NCT00813527 2006-02-01 Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels Phase 2 Completed
NCT00290251 2006-02-01 Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 Phase 2 Completed
NCT00302731 2006-02-01 Bioidentical 'Natural' Hormone Evaluation in Early Menopause Phase 2 Completed
NCT00303524 2006-02-01 Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients Phase 2 Completed
NCT00250432 2006-01-01 A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) Phase 3 Completed
NCT00258193 2006-01-01 Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS Phase 2 Completed
NCT00868127 2005-12-01 Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia Phase 3 Completed
NCT00283062 2005-12-01 Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy Phase 3 Completed
NCT00372697 2005-12-01 Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly Phase 3 Completed
NCT00288080 2005-12-01 Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer Phase 3 Active, Not Recruiting
NCT00315640 2005-12-01 Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation Phase 2 Completed
NCT01822678 2005-12-01 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder Phase 2 Completed
NCT00455689 2005-11-01 Understanding Experimentally Induced Hot Flushes Phase 2/Phase 3 Active, Not Recruiting
NCT00473512 2005-11-01 A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy Phase 1/Phase 2 Completed
NCT00249899 2005-11-01 Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia Phase 3 Terminated
NCT00903409 2005-11-01 Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects Phase 3 Completed
NCT00248131 2005-11-01 Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Phase 3 Terminated
NCT00248157 2005-11-01 Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Phase 3 Terminated
NCT00263081 2005-11-01 Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia Phase 3 Terminated
NCT00240253 2005-10-01 A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes Phase 4 Completed
NCT00249912 2005-10-01 Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia Phase 3 Completed
NCT00268697 2005-10-01 Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia. Phase 3 Completed
NCT00256178 2005-10-01 Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. Phase 3 Completed
NCT00251680 2005-10-01 Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy. Phase 3 Completed
NCT00182754 2005-10-01 Octreotide in Treating Patients With Cancer-Related Malignant Ascites Phase 3 Active, Not Recruiting
NCT00189514 2005-09-01 A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects Phase 2 Completed
NCT00225433 2005-09-01 Luteal Phase FSH in the IVF Poor Responder Phase 4 Completed
NCT00211458 2005-09-01 Treatment of Age-Related Macular Degeneration With Anecortave Acetate Phase 2 Completed
NCT00128531 2005-09-01 Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer Phase 3 Completed
NCT00217659 2005-09-01 S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Phase 2 Withdrawn
NCT00143663 2005-09-01 Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol Phase 3 Completed
NCT00146211 2005-09-01 TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease Phase 3 Completed
NCT00143676 2005-08-01 Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia Phase 3 Completed
NCT00239993 2005-08-01 A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® Phase 4 Completed
NCT00225420 2005-08-01 Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer Phase 1/Phase 2 Completed
NCT00257426 2005-07-01 Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer Phase 2 Completed
NCT00707421 2005-07-01 Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes Phase 3 Completed
NCT00123110 2005-07-01 Insulin Resistance and Testosterone in Women Phase 2 Completed
NCT00226655 2005-07-01 An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Phase 3 Completed
NCT02170064 2005-06-01 Pharmacokinetics, Efficacy and Tolerability of BIA 2-093 Phase 2 Completed
NCT00379964 2005-06-01 A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) Phase 3 Completed
NCT00127075 2005-06-01 POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis Phase 3 Active, Not Recruiting
NCT00211978 2005-05-01 EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) Phase 3 Completed
NCT00112281 2005-05-01 A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack Phase 3 Terminated
NCT00148330 2005-05-01 Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study Phase 2/Phase 3 Completed
NCT00273728 2005-05-01 BaSES Trial: Basel Starch Evaluation in Sepsis Phase 4 Completed
NCT00333216 2005-05-01 Anecortave Acetate Risk-Reduction Trial (AART) Phase 3 Terminated
NCT00118482 2005-05-01 Clinical Trial for the Prevention of Vasovagal Syncope Phase 4 Completed
NCT00112021 2005-05-01 A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects Phase 2 Completed
NCT00107666 2005-04-01 CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB) Phase 2 Terminated
NCT00148265 2005-04-01 A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema Phase 2/Phase 3 Completed
NCT00299507 2005-03-01 Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) Phase 3 Completed
NCT01477632 2005-03-01 Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women Phase 1 Completed
NCT00135226 2005-03-01 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase 4 Active, Not Recruiting
NCT00110045 2005-02-01 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Phase 2 Completed
NCT00211939 2005-01-01 CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients Phase 4 Completed
NCT00211887 2005-01-01 Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx Phase 3 Completed
NCT00203047 2005-01-01 Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate Phase 4 Terminated
NCT00196755 2004-12-01 Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis Phase 3 Completed
NCT00637572 2004-12-01 Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss Phase 2 Completed
NCT00203099 2004-12-01 Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine Phase 2 Completed
NCT00957372 2004-12-01 Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy Phase 3 Completed
NCT00839449 2004-12-01 Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study Phase 4 Completed
NCT00487994 2004-11-01 Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia Phase 3 Completed
NCT00240032 2004-10-01 A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. Phase 4 Completed
NCT00103376 2004-10-01 Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer Phase 2 Completed
NCT00104715 2004-10-01 Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer Phase 3 Active, Not Recruiting
NCT00193856 2004-10-01 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase 3 Active, Not Recruiting
NCT00212368 2004-10-01 Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan. Phase 3 Completed
NCT00752635 2004-09-01 Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris Phase 4 Completed
NCT00864643 2004-09-01 Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia Phase 2 Completed
NCT00170729 2004-08-01 A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery Phase 4 Completed
NCT00427245 2004-08-01 Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer Phase 3 Completed
NCT00349258 2004-08-01 The Use of GnRH Agonist Trigger in the Prevention of OHSS Phase 4 Completed
NCT00134992 2004-08-01 A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers Phase 4 Completed
NCT00444561 2004-08-01 An Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects Phase 2 Completed
NCT00458458 2004-08-01 Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) Phase 3 Active, Not Recruiting
NCT00099086 2004-07-01 Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer Phase 1 Active, Not Recruiting
NCT00202995 2004-07-01 Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS Phase 4 Terminated
NCT00957047 2004-07-01 Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy Phase 3 Completed
NCT00957684 2004-07-01 Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures Phase 3 Completed
NCT00081159 2004-07-01 Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Phase 2 Completed
NCT00584857 2004-07-01 A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer Phase 2 Completed
NCT00203112 2004-06-01 Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline Phase 2 Completed
NCT00184795 2004-05-01 Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations Phase 3 Completed
NCT00292071 2004-05-01 Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) Phase 2 Completed
NCT00211367 2004-04-01 Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) Phase 2 Terminated
NCT00082537 2004-04-01 MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) Phase 2 Completed
NCT00082524 2004-04-01 Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) Phase 2 Completed
NCT01011751 2004-04-01 Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma Phase 3 Completed
NCT00428311 2004-04-01 Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS Phase 4 Completed
NCT00307398 2004-03-01 Anecortave Acetate Risk-Reduction Trial (AART) Phase 3 Terminated
NCT00075192 2004-03-01 CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer Phase 1/Phase 2 Completed
NCT00078338 2004-03-01 Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis Phase 4 Completed
NCT00083824 2004-03-01 Estrogen, HDL, and Coronary Heart Disease in Women Phase 2/Phase 3 Completed
NCT00070148 2004-03-01 Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer Phase 3 Completed
NCT00932321 2004-01-01 Study of Safety and Efficacy of an Oral Contraceptive Phase 3 Completed
NCT00666224 2004-01-01 Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome Phase 3 Completed
NCT00076440 2003-12-01 Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study Phase 2 Completed
NCT00076531 2003-12-01 Clinical Trial for Prostate Cancer Phase 3 Completed
NCT00075868 2003-12-01 Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer Phase 3 Completed
NCT00466856 2003-12-01 Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Phase 2 Terminated
NCT00767286 2003-11-01 Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer Phase 3 Completed
NCT00987376 2003-11-01 Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration Phase 1 Completed
NCT00068601 2003-10-01 S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Phase 3 Active, Not Recruiting
NCT00238355 2003-08-01 Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems Phase 2 Terminated
NCT00294216 2003-08-01 Omacor and Placebo in Carotid Plaque Stability Phase 3 Completed
NCT00202982 2003-08-01 A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose Phase 2 Completed
NCT00835211 2003-07-01 Desmopressin Acetate 0.2 mg Tablets, Fasting Phase 1 Completed
NCT00290589 2003-06-01 A Trial of Corticosteroids for Low Back Pain Phase 3 Completed
NCT00500110 2003-06-01 Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer Phase 2 Completed
NCT00203073 2003-06-01 A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. Phase 2 Completed
NCT00065728 2003-06-01 Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD Phase 3 Terminated
NCT00267319 2003-06-01 FOCUS Fatigue Outcome in Copaxone USers Phase 4 Completed
NCT00066248 2003-06-01 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Phase 2 Completed
NCT00067015 2003-05-01 Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer Phase 3 Completed
NCT00211484 2003-05-01 Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. Phase 2 Completed
NCT00220194 2003-04-01 A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer Phase 4 Completed
NCT00108004 2003-04-01 Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Phase 3 Completed
NCT00621179 2003-03-01 Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF Phase 4 Completed
NCT00328614 2003-03-01 Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer Phase 1 Completed
NCT00063310 2003-03-01 ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation Phase 2 Completed
NCT00058994 2003-03-01 An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD Phase 3 Completed
NCT00242541 2003-03-01 Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas Phase 4 Terminated
NCT00801957 2003-03-01 Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis Phase 2 Completed
NCT00294463 2003-02-01 Effects of Tibolone Treatment on the Endometrium Phase 4 Completed
NCT01070979 2003-02-01 Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms. Phase 3 Completed
NCT00076869 2003-01-01 MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) Phase 2 Completed
NCT00363285 2003-01-01 Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer Phase 3 Recruiting
NCT00635154 2002-12-01 Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma Phase 2 Completed
NCT00001079 2002-12-01 A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss Phase 2 Completed
NCT00257283 2002-11-01 Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis Phase 4 Completed
NCT00429494 2002-11-01 GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients Phase 2 Completed
NCT00055731 2002-11-01 Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse Phase 3 Active, Not Recruiting
NCT00053911 2002-11-01 Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer Phase 3 Terminated
NCT00107107 2002-11-01 Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Phase 3 Completed
NCT01878578 2002-11-01 The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients Phase 1 Terminated
NCT00392535 2002-10-01 Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer Phase 3 Recruiting
NCT00345046 2002-09-01 A Comparison of Three Different Formulations of Prednisolone Acetate 1% Phase 4 Completed
NCT00044707 2002-08-01 Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide Phase 2 Completed
NCT01160315 2002-07-01 Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure Phase 2/Phase 3 Active, Not Recruiting
NCT00042601 2002-07-01 Evaluation of the Effect of Pramlintide on Satiety and Food Intake Phase 2 Completed
NCT00042471 2002-06-01 Evaluation of the Bioavailability of Pramlintide Phase 2 Completed
NCT00041483 2002-06-01 Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD Phase 3 Completed
NCT00041275 2002-05-01 Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Phase 3 Completed
NCT00033605 2002-04-01 Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis Phase 3 Completed
NCT00830414 2002-04-01 Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women Phase 1 Completed
NCT00042458 2002-04-01 Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Phase 3 Completed
NCT00167518 2002-03-01 Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) Phase 2/Phase 3 Completed
NCT00653757 2002-03-01 Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer Phase 1/Phase 2 Completed
NCT00211471 2002-03-01 Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). Phase 2 Terminated
NCT00211354 2002-03-01 Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.) Phase 2 Withdrawn
NCT00211328 2002-03-01 Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.). Phase 2 Completed
NCT00211315 2002-03-01 Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.) Phase 2 Completed
NCT00332553 2002-02-01 Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen Phase 2 Completed
NCT00032006 2002-02-01 Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Phase 2 Completed
NCT00244920 2002-01-01 Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer Phase 2 Withdrawn
NCT00205777 2001-12-01 Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women Phase 3 Completed
NCT01237327 2001-11-01 Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer Phase 3 Completed
NCT00026377 2001-11-01 SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Phase 1 Completed
NCT00283803 2001-10-01 To Lengthen the Duration of the Off-Treatment of Intermittent Androgen Suppression Phase 2 Active, Not Recruiting
NCT00220350 2001-10-01 Lupron Sex Offender Therapy Phase 2/Phase 3 Active, Not Recruiting
NCT00096798 2001-09-01 Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression Phase 3 Completed
NCT00634361 2001-09-01 Ethyl-EPA Treatment of Prodromal Patients Phase 2/Phase 3 Completed
NCT00419146 2001-09-01 Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants Phase 2/Phase 3 Completed
NCT00047099 2001-08-01 Combination Chemotherapy in Treating Women With Breast Cancer Phase 3 Completed
NCT01705249 2001-08-01 Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women Phase 4 Completed
NCT00481169 2001-07-01 Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women Phase 3 Completed
NCT00169299 2001-06-01 Herbal Alternatives for Menopause Symptoms (HALT Study) Phase 4 Active, Not Recruiting
NCT00632983 2001-06-01 Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer Phase 3 Active, Not Recruiting
NCT00016341 2001-05-01 Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer Phase 3 Terminated
NCT00021450 2001-04-01 Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer Phase 3 Active, Not Recruiting
NCT00014586 2001-01-01 Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer Phase 3 Terminated
NCT00006799 2000-10-01 Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Phase 3 Completed
NCT00031785 2000-09-01 Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer Phase 3 Completed
NCT00012090 2000-09-01 Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum Phase 2 Completed
NCT00008359 2000-08-01 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Phase 3 Completed
NCT00010010 2000-06-01 Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer Phase 2 Completed
NCT00346866 2000-05-01 Anecortave Acetate Versus Placebo in AMD Patients Following PDT Phase 2 Completed
NCT00684905 2000-04-01 Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy Phase 2 Completed
NCT01697384 2000-04-01 Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer Phase 3 Completed
NCT00031707 2000-03-01 Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite Phase 3 Completed
NCT00004635 2000-02-01 Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer Phase 3 Completed
NCT00130845 2000-02-01 Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy Phase 3 Completed
NCT01472315 2000-01-01 Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities Phase 2/Phase 3 Completed
NCT00004912 2000-01-01 Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss Phase 2 Completed
NCT00006269 1999-12-01 Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer Phase 3 Terminated
NCT00291369 1999-12-01 Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis Phase 3 Completed
NCT00005623 1999-12-01 Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer Phase 3 Completed
NCT00131144 1999-11-01 Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy Phase 3 Completed
NCT00004895 1999-10-01 Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery Phase 2 Completed
NCT00001146 1999-10-01 Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial Phase 2 Completed
NCT00003645 1999-06-01 Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer Phase 3 Active, Not Recruiting
NCT00003915 1999-05-01 Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer Phase 2 Active, Not Recruiting
NCT00346957 1999-04-01 A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration Phase 2 Completed
NCT00321126 1999-01-01 Zinc Supplementation in Shigella Patients Phase 3 Completed
NCT00003653 1999-01-01 Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer Phase 3 Completed
NCT00004058 1998-12-01 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder Phase 1 Terminated
NCT00003283 1998-07-01 Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma Phase 2 Completed
NCT00003394 1998-04-01 Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer Phase 1/Phase 2 Completed
NCT00005975 1998-04-01 S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer Phase 3 Completed
NCT00002779 1998-02-01 Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma Phase 2 Active, Not Recruiting
NCT00002996 1998-02-01 Flecainide in Treating Patients With Chronic Neuropathic Pain Phase 2 Completed
NCT00091728 1997-09-01 Hormonal Contraception and Risk of Chlamydia and Gonorrhea Phase 4 Terminated
NCT00003771 1997-09-01 Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer Phase 3 Completed
NCT00002889 1997-05-01 Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer Phase 2 Completed
NCT00003124 1997-05-01 Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer Phase 2 Completed
NCT00223665 1997-01-01 Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy Phase 2 Recruiting
NCT00003057 1996-11-01 Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer Phase 3 Completed
NCT00231738 1996-11-01 Protective Effect of EPA on Cardiovascular Events Phase 4 Completed
NCT00002881 1996-10-01 Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer Phase 3 Completed
NCT00002864 1996-08-01 Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer Phase 3 Completed
NCT00008073 1996-01-01 Octreotide and Doxorubicin in Treating Patients With Advanced Cancer Phase 1 Completed
NCT00002651 1995-05-01 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Phase 3 Recruiting
NCT00769548 1995-04-01 Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer Phase 3 Active, Not Recruiting
NCT00002633 1995-03-01 Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer Phase 3 Completed
NCT00002597 1994-10-01 Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer Phase 3 Completed
NCT00203021 1994-07-01 Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness. Phase 4 Active, Not Recruiting
NCT00002680 1994-02-01 Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer Phase 2 Completed
NCT00004338 1993-10-01 Study of Zinc for Wilson Disease Phase 4 Completed
NCT00002582 1993-06-01 Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer Phase 3 Completed
NCT00002580 1993-06-01 Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer Phase 3 Completed
NCT00660010 1991-01-01 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase 3 Completed
NCT00004311 1989-07-01 Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome Phase 2 Completed
NCT00191113 1989-02-01 Somatropin Treatment to Final Height in Turner Syndrome Phase 3 Completed
NCT00002465 1987-12-01 High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma Phase 1/Phase 2 Active, Not Recruiting
NCT00002460 1987-09-01 Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer Phase 3 Active, Not Recruiting
NCT00849082 1987-05-01 Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer Phase 3 Completed

(Browse) Purchasable Analogs in ZINC

ZINC ACETATE

Dosages

Route Formulation Per Unit Dose
Subcutaneous Injection
Subcutaneous Powder, For Injection Suspension 0.23%
Topical Lotion
Topical Solution
Topical Swab

More Information

Usage Over Time

Data provided by OpenFDA

Comments